What changed today in Aesthetics & Longevity: 2 trial updates

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

What changed

1. New trial registered: Comparative Study of The Efficacy and Safety of Subcision Combined With Injection of Exosomes Versus Subcision Alone in Treatment of Atrophic Post-…[1]
2. New trial registered: AWAKENING (Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia)[2]

Who this affects

• Med spas
• Medical directors
• Prescribers
• Practice owners & operators
• Pharmacies

What to watch next

No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.

Source file

1. [1]
   New trial registered: Comparative Study of The Efficacy and Safety of Subcision Combined With Injection of Exosomes Versus Subcision Alone in Treatment of Atrophic Post-… (opens the source in a new tab)

   Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Oct 29, 2026

2. [2]
   New trial registered: AWAKENING (Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia) (opens the source in a new tab)

   Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Oct 29, 2026

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.